Novartis Backs Off From 2016 Date for Testing Google Autofocus Lens

ZURICH – Novartis has abandoned a 2016 goal to start testing its autofocus contact lens on people, though it said the groundbreaking product it is making with internet giant Google is “progressing steadily.” “It is too early to say when exactly human clinical trials for these lenses will begin,” a spokeswoman for the Basel-based drugmaker said

[ Read More ]

New Heart Drugs Struggle to Win Sales as Doctors Hold Back

By Ben Hirschler LONDON, April 21- New heart drugs hailed as breakthrough treatments by researchers are struggling to gain traction among prescribing doctors, posing a headache for makers such as Novartis, which reported more weak sales for its Entresto medicine on Thursday. Novartis has touted the novel heart failure drug as a $5 billion-a-year seller

[ Read More ]